Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease
Å Riis, TC Martinsen, HL Waldum… - Scandinavian journal of …, 2012 - Taylor & Francis
Background and aims: Patients with Crohn's disease (CD) may need anti-inflammatory
drugs for decades. Anti-TNF-α agents have good efficacy and adverse events similar to …
drugs for decades. Anti-TNF-α agents have good efficacy and adverse events similar to …
Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease
A Riis, TC Martinsen, HL Waldum… - Scandinavian …, 2012 - pubmed.ncbi.nlm.nih.gov
Background and aims Patients with Crohn's disease (CD) may need anti-inflammatory drugs
for decades. Anti-TNF-α agents have good efficacy and adverse events similar to placebo in …
for decades. Anti-TNF-α agents have good efficacy and adverse events similar to placebo in …
[引用][C] Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease
A RIIS, TC MARTINSEN, HL WALDUM… - Scandinavian …, 2012 - pascal-francis.inist.fr
Clinical experience with infliximab and adalimumab in a single-center cohort of patients
with Crohn's disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
with Crohn's disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …